Delivery Order SPE2DB22D2009-SPE2DB25FM1SE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $7,204.23 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 19, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $29,013.01 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,069.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 150 mg capsules (30-count unit). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under the...
- The Defense Logistics Agency awarded a delivery order valued at $68,123.33 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100s). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 11, 2025. The award was made without a set-aside designation, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count), with a contract ceiling value of $28,600.52. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement supporting federal pharmaceutical supply needs. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $77,696.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.74 to AmerisourceBergen Drug Corp for 60-count bottles of Rifampin 300 mg capsules, with delivery to the company's headquarters in Conshohocken, Pennsylvania. The contract was awarded on August 6, 2025, under firm fixed price terms with an ultimate completion date of August 7, 2025, and utilized no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $17,169.04 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count) on July 17, 2025, with a completion date of July 18, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,336.50. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively awarded. The ultimate completion date is September 12, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1SEDelivery Order
The Defense Logistics Agency awarded a $14,989.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract, which is a non-set-aside competitive award, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that supports military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. As a prime contractor for the DLA's pharmaceutical procurement operations, the company demonstrates significant capacity to deliver diverse pharmaceutical products across multiple therapeutic domains through competitive contract vehicles. The Rifampin order represents a routine pharmaceutical supply requirement, with the product serving as a critical antibiotic treatment within military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 9/25/25 |